The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
Official Title: A Phase IIb, Randomized, Open, Parallel-Group, Multi-Center Trial to Assess the Efficacy and Safety of Belotecan(CamtoBell Inj.) or Topotecan in Patients With Relapsed Small Cell Lung Cancer
Study ID: NCT01497873
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of Belotecan administered 5 days every 3 weeks in comparison to Topotecan in Patients with relapsed small cell lung cancer.
Detailed Description: A Phase Ⅱb, Randomized, Open, Parallel-Group, Multi-Center Trial to Assess the Efficacy and Safety of Belotecan(CamtoBell inj.) or Topotecan in Patients with Relapsed Small Cell Lung Cancer
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Chungbuk University Hospital, Daegu, , Korea, Republic of
Keimyung University Dongsan Center, Daegu, , Korea, Republic of
National Cancer Center, Goyang, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
CHA Bundang Medical Center, Seoul, , Korea, Republic of
Chung-Ang University hospital, Seoul, , Korea, Republic of
Kyung Hee University Medical Hospital, Seoul, , Korea, Republic of
Seoul National University Boramae Medical Center, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Seoul St. Marys Hospital, Seoul, , Korea, Republic of
Seoul Veterans Hospital, Seoul, , Korea, Republic of
Yonsei Cancer Center, Seoul, , Korea, Republic of
Ajou University Hospital, Suwon, , Korea, Republic of
St. Vincents Hospital, Suwon, , Korea, Republic of
Name: Heung Tae Kim, M.D., Ph.D
Affiliation: National Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Name: Jin Hyoung Kang, M.D., Ph.D
Affiliation: The Catholic University of Korea Seoul St. Marys Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jin Young Kim, M.D., Ph.D
Affiliation: Keimyung University Dongsan Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Dong-Wan Kim, M.D., Ph.D
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Sang-We Kim, M.D., Ph.D
Affiliation: Asan Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Hye Ryeon Kim, M.D., Ph.D
Affiliation: Yonsei Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Name: Jin Hyuk Choi, M.D., Ph.D
Affiliation: Ajou University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Ki Hyeong Lee, M.D., Ph.D
Affiliation: Chungbuk National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Ho Jung An, M.D., Ph.D
Affiliation: St. Vincents Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Chi Hoon Maeng, M.D., Ph.D
Affiliation: Kyung Hee University Medical Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jin-Soo Kim, M.D., Ph.D
Affiliation: SMG-SNU Boramae Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Joung Soon Jang, M.D., Ph.D
Affiliation: Choung Ang University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Bong Seog Kim, M.D., Ph.D
Affiliation: Seoul Veterans Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Joo-Hang Kim, .D., Ph.D
Affiliation: CHA Bundang Medical Center
Role: PRINCIPAL_INVESTIGATOR